全文获取类型
收费全文 | 59483篇 |
免费 | 3908篇 |
国内免费 | 121篇 |
专业分类
耳鼻咽喉 | 563篇 |
儿科学 | 2385篇 |
妇产科学 | 1589篇 |
基础医学 | 7480篇 |
口腔科学 | 636篇 |
临床医学 | 9097篇 |
内科学 | 10195篇 |
皮肤病学 | 772篇 |
神经病学 | 5628篇 |
特种医学 | 1231篇 |
外科学 | 5163篇 |
综合类 | 673篇 |
一般理论 | 111篇 |
预防医学 | 8210篇 |
眼科学 | 780篇 |
药学 | 3935篇 |
中国医学 | 68篇 |
肿瘤学 | 4996篇 |
出版年
2023年 | 305篇 |
2022年 | 466篇 |
2021年 | 1083篇 |
2020年 | 736篇 |
2019年 | 1139篇 |
2018年 | 1298篇 |
2017年 | 1050篇 |
2016年 | 1141篇 |
2015年 | 1313篇 |
2014年 | 1820篇 |
2013年 | 2968篇 |
2012年 | 4144篇 |
2011年 | 4457篇 |
2010年 | 2472篇 |
2009年 | 2238篇 |
2008年 | 4031篇 |
2007年 | 4287篇 |
2006年 | 4111篇 |
2005年 | 4225篇 |
2004年 | 4007篇 |
2003年 | 3765篇 |
2002年 | 3473篇 |
2001年 | 590篇 |
2000年 | 457篇 |
1999年 | 579篇 |
1998年 | 728篇 |
1997年 | 633篇 |
1996年 | 521篇 |
1995年 | 512篇 |
1994年 | 461篇 |
1993年 | 372篇 |
1992年 | 336篇 |
1991年 | 277篇 |
1990年 | 249篇 |
1989年 | 264篇 |
1988年 | 251篇 |
1987年 | 221篇 |
1986年 | 233篇 |
1985年 | 206篇 |
1984年 | 228篇 |
1983年 | 197篇 |
1982年 | 236篇 |
1981年 | 227篇 |
1980年 | 178篇 |
1979年 | 125篇 |
1978年 | 139篇 |
1977年 | 71篇 |
1976年 | 88篇 |
1975年 | 79篇 |
1974年 | 99篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献
13.
14.
15.
Tarentola annularis is a climbing gecko with a wide distribution in Africa north of the equator. In the present paper, we describe the development of the osteocranium of this lizard, from the first appearance of the cranial elements up to the point of hatching. This is based on a combination of histology and cleared and stained specimens. This is the first comprehensive account of gekkotan pre-hatching skull development based on a comprehensive series of embryos, rather than a few selected stages. Given that Gekkota is now widely regarded as representing the sister group to other squamates, this account helps to fill a significant gap in the literature. Moreover, as many authors have considered features of the gekkotan skull and skeleton to be indicative of paedomorphosis, it is important to know whether this hypothesis is supported by delays in the onset of cranial ossification. In fact, we found the sequence of cranial bone ossification to be broadly comparable to that of other squamates studied to date, with no significant lags in development. 相似文献
16.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
17.
18.
19.
20.